Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Status epilepticus: Analysis of refractory cases

https://doi.org/10.14412/2074-2711-2016-1S-35-37

Full Text:

Abstract

Objective: to analyze refractory status epilepticus (SE) cases.
Patients and methods. Fifteen female patients aged 21 to 62 years with refractory SE were comprehensively examined using long-term electroencephalography monitoring. The investigators evaluated the efficiency of treatment regimens with intravenous antiepileptic drugs (AEDs), such as diazepam (DZP); valproic acid (VPA); levetiracetam; and lacosamide and their combinations, at the prehospital and hospital stages, as well as SE therapy complications noted only in the intravenous administration of narcotics (propofol, sodium thiopental).
Results and discussion. A fetal outcome due to multiple organ dysfunction indirectly related to SE was recorded in 2 (13.3%) patients with acute symptomatic status. SE was abolished in the other 13 cases. The preliminary findings may suggest that it is appropriate to prescribe VPA just at the prehospital stage. The co-administration of VPA and DZP substantially enhances the efficiency of SE therapy. The maximum acceptable doses of AEDs using the whole available therapeutic arsenal should be administered within the first hours of acute symptomatic SE.

About the Authors

B. P. Gladov
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Department of Nervous System Diseases, Faculty of General Medicine


O. A. Podgornaya
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Department of Nervous System Diseases, Faculty of General Medicine


P. N. Vlasov
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Department of Nervous System Diseases, Faculty of General Medicine


References

1. DeLorenzo RJ, Hauser WA, Towne AR. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. Apr 1996;46(4):1029-35. doi: 10.1212/WNL.46.4.1029

2. Rosenow F, Hamer HM, Knake S. The epidemiology of convulsive and nonconvulsive status epilepticus. Epilepsia. 2007;48 Suppl. 8:82-4. doi: 10.1111/j.1528-167.2007.01359.x

3. Beghi E, Carpio A, Forsgren L, et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010;51:671-5. doi: 10.1111/j.1528-1167.2009.02285.x

4. Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults. Lancet Neurol. 2011;10:922-30. doi: 10.1016/S1474-4422(11)70187-9

5. Shorvon S, Ferlisi M. The Treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134(10):2802-18.doi: 10.1093/brain/awr215

6. Власов ПН. Внутривенные формы противоэпилептических препаратов в России. Неврология, нейропсихиатрия, психосоматика. 2014;6(1S):48-53 [Vlasov PN. Intravenous Antiepileptic Drugs in Russia. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2014;6(1S):48-53. (In Russ.)]. doi: 10.14412/2074-2711-2014-1S-48-53

7. Karlov VA. Mechanisms of Brain Antiepileptic Defense, (abstr). 20th International Epilepsy Congress, Oslo, Norway. Epilepsia. 1993;34 Suppl 2:47.

8. Rossetti F, de Araujo Furtado M, Pak T, et al. Combined diazepam and HDAC inhibitor treatment protects against seizures and neuronal damage caused by soman exposure. Neurotoxicology. 2012 Jun;33(3):500-11. doi: 10.1016/j.neuro.2012.02.010

9. Карлов ВА. Эпилепсия у детей и взрослых, женщин и мужчин. Москва: Медицина; 2010. 720 с. [Karlov VA. Epilepsiya u detei i vzroslykh, zhenshchin i muzhchin [Epilepsy in children and adults, women and men]. Moscow: Medicina; 2010. 720 p.].

10. Sutter R, Marsch S, Fuhr P, et al. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology. 2014 Feb 25;82(8):656-64. doi:10.1212/WNL.0000000000000009


For citation:


Gladov B.P., Podgornaya O.A., Vlasov P.N. Status epilepticus: Analysis of refractory cases. Neurology, Neuropsychiatry, Psychosomatics. 2016;(1S):35-37. (In Russ.) https://doi.org/10.14412/2074-2711-2016-1S-35-37

Views: 299


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)